Sonnet BioTherapeutics Holdings, Inc.
SONNDelisted Dec 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106838
Sonnet BioTherapeutics Holdings, Inc. was delisted on Dec 2, 2025; its insiders filed their last Form 4 on Dec 4, 2025; 27 institutions reported holding it in 13F filings for Q3 2025, worth $3.53M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Sonnet BioTherapeutics Holdings, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 9 | 27 | +18 |
| Shares | 180.4K | 771.1K | +590.7K (+327.4%) |
| Value | $223.7K | $3.53M | +$3.31M (+1,478.4%) |
New holders (21)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 150,000 | $687.0K | 0.16% |
| Vanguard Group Inc | 96,382 | $441.4K | 0.00% |
| HRT Financial LP | 74,265 | $340.0K | 0.00% |
| Boothbay Fund Management, LLC | 56,339 | $258.0K | 0.01% |
| Goldman Sachs Group Inc | 55,134 | $252.5K | 0.00% |
| BIT Capital GmbH | 48,358 | $221.5K | 0.01% |
| Citadel Advisors LLC | 46,082 | $211.1K | 0.00% |
| Virtu Financial LLC | 26,266 | $120.0K | 0.01% |
| Morgan Stanley | 25,808 | $118.2K | 0.00% |
| State Street Corp | 22,534 | $103.2K | 0.00% |
| Northern Trust Corp | 17,860 | $81.8K | 0.00% |
| Two Sigma Investments, LP | 14,972 | $68.6K | 0.00% |
| Investment House LLC | 10,625 | $48.7K | 0.00% |
| Jane Street Group, LLC | 10,562 | $48.4K | 0.00% |
| JPMorgan Chase & Co | 7,537 | $34.5K | 0.00% |
| Larson Financial Group LLC | 4,303 | $19.7K | 0.00% |
| Clear Street Markets LLC | 1,000 | $4.58K | 0.00% |
| Advisory Services Network, LLC | 636 | $2.91K | 0.00% |
| Golden State Wealth Management, LLC | 202 | $925 | 0.00% |
| Citigroup Inc | 134 | $614 | 0.00% |
| Advisor Group Holdings, Inc. | 175 | $568 | 0.00% |
Sold out (3)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| MMCAP International Inc. SPC | 133,590 | $165.7K |
| XTX Topco Ltd | 13,668 | $16.9K |
| Raymond James Financial Inc | 6 | $7 |